Kymera Therapeutics, Inc. (KYMR)
NASDAQ: KYMR · Real-Time Price · USD
122.60
+0.09 (0.07%)
Oct 29, 2026, 4:00 PM EDT - Market closed

Kymera Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
373.37357.01120.26109.9768.447.98
Short-Term Investments
597.84491.27368.49264.92338.77394.44
Cash & Short-Term Investments
971.21848.28488.74374.88407.17442.42
Cash Growth
92.06%73.56%30.37%-7.93%-7.97%49.36%
Accounts Receivable
---18.762.540.14
Receivables
---18.762.540.14
Prepaid Expenses
27.3822.9421.5211.679.718.72
Total Current Assets
998.59871.21510.27405.32419.42451.27
Property, Plant & Equipment
78.6985.5397.86101.0822.2421.31
Long-Term Investments
674.67771.16362.1661.43152.33125.19
Other Long-Term Assets
15.3214.917.747.939.158.14
Total Assets
1,7671,743978.04575.76603.13605.91

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
11.924.015.997.084.344.01
Accrued Expenses
63.3242.2734.8733.8627.522.97
Current Portion of Leases
13.5813.7613.116.353.943.6
Current Unearned Revenue
-22.9313.5837.8835.2661.74
Other Current Liabilities
0.910.240.220.520.30.23
Total Current Liabilities
89.7283.2167.7785.6971.3492.54
Long-Term Leases
63.0268.574.6578.3313.3914.36
Long-Term Unearned Revenue
-11.44-16.772839.3
Other Long-Term Liabilities
----0.250.07
Total Liabilities
152.74163.15142.42180.79112.98146.27

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.010.010.010.010.010.01
Additional Paid-In Capital
2,9582,6441,592926.27878.88689.28
Retained Earnings
-1,328-1,066-754.61-530.75-383.79-228.98
Comprehensive Income & Other
-14.741.8-1.49-0.55-4.95-0.66
Total Common Equity
1,6151,580835.62394.97490.15459.64
Shareholders' Equity
1,6151,580835.62394.97490.15459.64
Total Liabilities & Equity
1,7671,743978.04575.76603.13605.91

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
76.682.2587.7684.6717.3417.96
Net Cash (Debt)
1,5691,537763.14351.64542.16549.64
Net Cash Growth
75.39%101.43%117.02%-35.14%-1.36%24.71%
Net Cash Per Share
16.2718.1910.176.0210.0511.45
Filing Date Shares Outstanding
85.3781.6464.9461.1155.1851.67
Total Common Shares Outstanding
85.3381.3264.8955.5955.0451.5
Working Capital
908.87788442.5319.63348.07358.73
Book Value Per Share
18.9219.4212.887.118.918.93
Tangible Book Value
1,6151,580835.62394.97490.15459.64
Tangible Book Value Per Share
18.9219.4212.887.118.918.93
Machinery
-15.7714.756.745.84.02
Leasehold Improvements
-42.9944.017.87.87.74
SEC Filings: 10-K · 10-Q